Advertisement

Topics

Pfizer Grows In Rare Disease With $810m Dwarfism Company Buy

08:36 EDT 9 May 2019 | SCRIP

Pfizer adds to its rare disease portfolio with purchase of Therachon, a Swiss company working in achondroplasia. But whether it...

      

Related Stories

 

Original Article: Pfizer Grows In Rare Disease With $810m Dwarfism Company Buy

NEXT ARTICLE

More From BioPortfolio on "Pfizer Grows In Rare Disease With $810m Dwarfism Company Buy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...